• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Antisense Therapeutics Ltd

+ Add to Watchlist

ANP:AU

0.1600 AUD 0.00000.00%

As of 01:59:08 ET on 04/17/2014.

Snapshot for Antisense Therapeutics Ltd (ANP)

Open: 0.1600 Day's Range: 0.1500 - 0.1600 Volume: 181,127
Previous Close: 0.1600 52wk Range: 0.0900 - 0.2350 1-Yr Rtn: +77.78%

Stock Chart for ANP

No chart data available.
  • ANP:AU 0.1600
  • 1D
  • 1M
  • 1Y
0.1600
Interactive ANP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -0.0190
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 23.06
Shares Outstanding (M) 144.10
30 Day Average Volume 980,294
Price/Book (mrq) 6.2590
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/18/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANP

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for ANP

Antisense Therapeutics Limited develops and markets drugs for treatment of diseases like psoriasis, multiple sclerosis, autoimmune, cancer, metabolic and cardiovascular. The drugs are based on small synthetic genetic molecules. The Company has collaboration with Isis Pharmaceuticals in the United States, which provides the Company access to drug development technology.

Mark P DiamondCEO/Managing DirectorPhillip HainsCFO/Secretary
More Company Profile & Key Executives for ANP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil